Asian Spectator


The Times

.

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

  • Written by C. Michael White, Distinguished Professor of Pharmacy Practice, University of Connecticut
CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and scienceSo many diseases to treat, so little money and time.Andriy Onufriyenko/Moment via Getty Images

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical industry decide which...

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-libraryzlibrary.jojobetสล็อตสล็อตjojobetstakejojobetStreamEastStreamEasthitbet girişroyalbetjojobetjojobetcasino siteleriPadişahbetPadişahbetDizipalStreamEastPadişahbetGalabetmostbetjojobetjojobetcasibomhttps://chantilly-montessori-school.vercel.app/esim senegalbetparkbetparknakitbahisjojobettelegram下载jojobetmeritking